Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06434168

Impact of Yoga on Cognitive Function

A Pilot and Feasibility Study of a Yoga Intervention in Heart Failure Patients With Mild Cognitive Impairment

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Auburn University · Academic / Other
Sex
All
Age
55 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Mild cognitive impairment is highly prevalent in patients with heart failure and results in poor well-being and quality of life. While yoga has proven effective in promoting cognitive health in older adults through its gentle movements, controlled breathing, and meditation, its effects on patients with heart failure remain unknown. Therefore, this feasibility and pilot study plans to deliver a 12-week yoga intervention and test its effects on cognitive function in patients with heart failure and mild cognitive impairment.

Detailed description

A prospective, 2-arm comparative feasibility design will be used. The investigators will enroll 24 patients with a confirmed heart failure diagnosis with mild cognitive impairment. Patients will be randomized equally into yoga intervention or control group. Patients in the yoga intervention group will receive a 60-minute yoga session twice per week for 12-week. Survey, cognitive function data, MRI scans, and blood samples will be collected at baseline and at 3 months (after completion of yoga intervention).

Conditions

Interventions

TypeNameDescription
BEHAVIORALYoga interventionPatients in the yoga group will receive a 60-minute session, twice per week over 12 weeks for a total of 24 sessions. Each yoga session consists of a warm-up, yoga postures standing or seated depending on the capability of the patient, and relaxation.
BEHAVIORALControl conditionPatients in the control group will receive care-as-usual from their healthcare providers and will be asked to avoid engaging in yoga during their 3 months in the study.

Timeline

Start date
2024-07-16
Primary completion
2027-06-30
Completion
2027-12-31
First posted
2024-05-30
Last updated
2026-04-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06434168. Inclusion in this directory is not an endorsement.